Resultado da Busca
Há 4 dias · Merck Sharp & Dohme Corp. engages in the research, development, and distribution of vaccines, prescription drugs, and animal health products. The company is headquartered in Whitehouse Station, NJ.
- (27)
- MERCK & CO., INC.
Há 2 dias · Speaker or member of speakers bureau for: AbbVie Inc.; AstraZeneca; BioNtech; Cepheid; Copan; Gilead Sciences, Inc.; GlaxoSmithKline; Janssen-Cilag; Merck Sharp & Dohme; Pfizer, Inc.; Roche; Shionogi & Co., Ltd.; ViiV Healthcare. Research funding from: Gilead Sciences, Inc.; Janssen Pharmaceuticals; ViiV Healthcare
Há 2 dias · Lund, Sweden – May 23, 2024 – BioInvent International AB (“BioInvent”) (Nasdaq Stockholm: BINV), a biotech company focused on the discovery and development of novel and first-in-class immune-modulatory antibodies for cancer immunotherapy, today announced promising Phase 1 data for BI-1206 in combination with MSD’s (Merck & Co., Inc., Rahway, NJ, USA) anti-PD-1 therapy KEYTRUDA ...
Há 2 dias · Leading hypercholesterolemia companies such as Novartis Pharmaceuticals, Merck Sharp & Dohme LLC, Esperion Therapeutics, Inc., Arrowhead Pharmaceuticals, LIB Therapeutics LLC, Medpace, Inc ...
Há 3 dias · KUALA LUMPUR, May 22 — Merck Sharp & Dohme (MSD) has officially launched its latest 15-valent pneumococcal conjugate vaccine, Vaxneuvance, in Malaysia, as a new preventive option to protect paediatric and adult populations against invasive pneumococcal disease. This newest addition to Malaysia’s authorised pneumococcal vaccines extends its ...
Há 1 dia · The Phase 2 CORE-001 trial was conducted in collaboration with Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA. The combination of cretostimogene and pembrolizumab received FDA Breakthrough Therapy Designation in May 2023.
Há 2 dias · Consultant or advisor for: Adlai Nortye; AstraZeneca Pharmaceuticals LP; Bayer; Bicara Therapeutics; DRG (part of Clarivate); Genmab US; GlaxoSmithKline; Merck Healthcare KGaA; Merck Serono; Merck Sharp & Dohme; Mirati Therapeutics; Neutron Therapeutics Inc.; Seagen International BmbH
